Cargando…
Radionuclide therapy in the time of COVID-19
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297509/ https://www.ncbi.nlm.nih.gov/pubmed/32548661 http://dx.doi.org/10.1007/s00259-020-04921-9 |
| _version_ | 1783547021065453568 |
|---|---|
| author | Brabander, Tessa Hofland, Hans |
| author_facet | Brabander, Tessa Hofland, Hans |
| author_sort | Brabander, Tessa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7297509 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72975092020-06-17 Radionuclide therapy in the time of COVID-19 Brabander, Tessa Hofland, Hans Eur J Nucl Med Mol Imaging Letter to the Editor Springer Berlin Heidelberg 2020-06-16 2020 /pmc/articles/PMC7297509/ /pubmed/32548661 http://dx.doi.org/10.1007/s00259-020-04921-9 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Brabander, Tessa Hofland, Hans Radionuclide therapy in the time of COVID-19 |
| title | Radionuclide therapy in the time of COVID-19 |
| title_full | Radionuclide therapy in the time of COVID-19 |
| title_fullStr | Radionuclide therapy in the time of COVID-19 |
| title_full_unstemmed | Radionuclide therapy in the time of COVID-19 |
| title_short | Radionuclide therapy in the time of COVID-19 |
| title_sort | radionuclide therapy in the time of covid-19 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297509/ https://www.ncbi.nlm.nih.gov/pubmed/32548661 http://dx.doi.org/10.1007/s00259-020-04921-9 |
| work_keys_str_mv | AT brabandertessa radionuclidetherapyinthetimeofcovid19 AT hoflandhans radionuclidetherapyinthetimeofcovid19 |